Shell is reportedly exploring a potential sale of its chemicals assets in Europe and the U.S., according to the Wall Street Journal, citing sources familiar with the matter. The energy giant has engaged Morgan Stanley to conduct a strategic review of its chemicals operations.
Potential buyers could include private equity firms and Middle Eastern companies looking to expand in Western markets. The review is still in its early stages, and Shell has not made any final decisions. Among the assets being assessed is the Deer Park facility in Texas, located next to a refinery Shell sold to Pemex, Mexico’s state oil company.
This move follows Shell’s 2023 sale of its refining and chemicals hub in Singapore, one of the world's largest. The company has been restructuring under CEO Wael Sawan, prioritizing its most profitable sectors—oil, gas, and biofuels—while scaling back on renewables. Earlier this year, Shell warned of lower earnings in its chemicals and oil products division due to reduced seasonal demand.
In December, Reuters reported that Shell was stepping back from new offshore wind investments and restructuring its power division, which was once central to its energy transition strategy.
Shell and Morgan Stanley declined to comment on the potential asset sales.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



